• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌。1950年至1984年1345例病例的调查。

Colorectal carcinoma. A survey of 1345 cases 1950-1984.

作者信息

Ohman U

出版信息

Acta Chir Scand. 1985;151(8):675-9.

PMID:4096172
Abstract

A 35-year (1950-1984) experience of colorectal carcinoma is surveyed. Intendedly curative resection was performed in 941 (70%) of the 1345 patients, this proportion being constant throughout the study. The operative mortality was 4.6%, falling from 12% in the early 1950s to less than 1%. Five-year survival, calculated for 1066 patients seen in 1950-1979, was 35% overall and 49% after surgery with curative intent. Improved survival rates were mainly due to decline in operative mortality. In Dukes' stages A, B and C the respective 5-year rates were 83, 48 and 22%. Retention of the original Dukes' system is advocated. Further improvement in results probably cannot be achieved via surgical management. Intensive follow-up routines have not revealed significant numbers of curable recurrences, and adjuvant treatment has been disappointing. To improve the long-term prospects, earlier diagnosis seems to be essential. Screening for fecal occult blood may be valuable, but proof awaits the results of randomized clinical trials.

摘要

对35年(1950 - 1984年)间的结直肠癌治疗经验进行了调查。1345例患者中有941例(70%)接受了根治性切除,这一比例在整个研究期间保持稳定。手术死亡率为4.6%,从20世纪50年代初的12%降至不到1%。对1950 - 1979年间就诊的1066例患者计算的5年生存率,总体为35%,根治性手术后为49%。生存率的提高主要归因于手术死亡率的下降。在Dukes分期A、B和C期,5年生存率分别为83%、48%和22%。主张保留原有的Dukes分期系统。通过手术治疗可能无法进一步提高疗效。强化随访程序未发现大量可治愈的复发病例,辅助治疗效果也不尽人意。为改善长期预后,早期诊断似乎至关重要。粪便潜血筛查可能有价值,但尚需随机临床试验的结果加以证实。

相似文献

1
Colorectal carcinoma. A survey of 1345 cases 1950-1984.结直肠癌。1950年至1984年1345例病例的调查。
Acta Chir Scand. 1985;151(8):675-9.
2
Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma.
Gastroenterology. 1983 Sep;85(3):596-9.
3
Carcinoma of the colon and rectum. Results of treatment in 284 cases.结肠直肠癌。284例治疗结果。
Acta Chir Scand. 1984;150(2):177-82.
4
Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.仅接受手术切除治疗的结肠癌或直肠癌患者的预后因素。五年随访报告。
Cancer. 1996 Aug 1;78(3):403-8. doi: 10.1002/(SICI)1097-0142(19960801)78:3<403::AID-CNCR4>3.0.CO;2-K.
5
Recording of patients with colorectal cancer on a database: results and advantages.
Eur J Surg. 1994 Mar;160(3):175-8.
6
Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.根治性切除结直肠癌辅助化疗的随机对照试验五年结果。日本结直肠癌化疗研究组。
Jpn J Clin Oncol. 1995 Jun;25(3):91-103.
7
[Cancers of the rectum and colon in the Côte-d'Or department: treatment, prognosis].[科多尔省的直肠癌和结肠癌:治疗、预后]
Gastroenterol Clin Biol. 1985 Oct;9(10):704-11.
8
Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma.病理切缘和杜克分期对结直肠癌局部复发的影响
Am J Surg. 1985 Mar;149(3):323-6. doi: 10.1016/s0002-9610(85)80099-4.
9
Limited survival in the treatment of carcinomatosis from rectal cancer.直肠癌种植转移的治疗中生存期有限。
Dis Colon Rectum. 2005 Dec;48(12):2258-63. doi: 10.1007/s10350-005-0189-3.
10
Small but significant survival benefit in patients who undergo routine follow-up after colorectal cancer surgery.结直肠癌手术后接受常规随访的患者有虽小但显著的生存获益。
Eur J Surg Oncol. 2004 Dec;30(10):1093-7. doi: 10.1016/j.ejso.2004.06.018.

引用本文的文献

1
Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.辅助性围手术期门静脉或外周静脉化疗用于潜在可治愈性结直肠癌:一项随机对照试验的长期结果
Int J Colorectal Dis. 2008 Dec;23(12):1233-41. doi: 10.1007/s00384-008-0543-8. Epub 2008 Aug 8.
2
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.纤溶酶原激活剂及其抑制剂对杜克B期和C期结直肠癌患者生存预后的影响
Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306.
3
Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component.
通过循环中与IgA和IgM相关的分泌成分水平升高早期检测结直肠癌患者的肝转移
Br J Cancer. 1987 Nov;56(5):629-32. doi: 10.1038/bjc.1987.256.